Literature DB >> 11448532

Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells.

J Dörrie1, K Sapala, S J Zunino.   

Abstract

Carnosol, a phenolic compound extracted from the herb rosemary has been reported to have anti-cancer activity. We investigated whether carnosol was cytotoxic against several pro-B and pre-B acute lymphoblastic leukemia (ALL) lines. In all ALL lines tested, carnosol induced apoptotic cell death distinguished by loss of nuclear DNA, externalization of cell membrane phosphatidylserine, and depolarization of mitochondrial membranes. Flow cytometric measurement of Bcl-2 protein levels revealed that carnosol induced a 34-53% decrease in Bcl-2 in the cell population exhibiting a viable phenotype prior to detectable apoptotic changes in morphology. These results suggest that carnosol may be useful as a novel chemotherapeutic agent against B-lineage leukemias, and possibly other types of cancers that express high levels of the protective protein, Bcl-2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448532     DOI: 10.1016/s0304-3835(01)00549-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Evaluation of inhibitory effect and apoptosis induction of Zyzyphus Jujube on tumor cell lines, an in vitro preliminary study.

Authors:  Fatemeh Vahedi; Mohsen Fathi Najafi; Kazem Bozari
Journal:  Cytotechnology       Date:  2008-02-09       Impact factor: 2.058

2.  Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines.

Authors:  Ozlem Yesil-Celiktas; Canan Sevimli; Erdal Bedir; Fazilet Vardar-Sukan
Journal:  Plant Foods Hum Nutr       Date:  2010-06       Impact factor: 3.921

3.  Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.

Authors:  Alberto Valdés; Virginia García-Cañas; Konstantin A Artemenko; Carolina Simó; Jonas Bergquist; Alejandro Cifuentes
Journal:  Mol Cell Proteomics       Date:  2016-11-10       Impact factor: 5.911

Review 4.  Carnosol: a promising anti-cancer and anti-inflammatory agent.

Authors:  Jeremy J Johnson
Journal:  Cancer Lett       Date:  2011-03-05       Impact factor: 8.679

5.  Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1.

Authors:  Julia Bauer; Susanne Kuehnl; Judith M Rollinger; Olga Scherer; Hinnak Northoff; Hermann Stuppner; Oliver Werz; Andreas Koeberle
Journal:  J Pharmacol Exp Ther       Date:  2012-04-16       Impact factor: 4.030

6.  Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary.

Authors:  Auxiliadora López-Jiménez; Melissa García-Caballero; Miguel Ángel Medina; Ana R Quesada
Journal:  Eur J Nutr       Date:  2011-12-16       Impact factor: 5.614

7.  Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis.

Authors:  Yo-ichi Ishida; Masao Yamasaki; Chizuko Yukizaki; Kazuo Nishiyama; Hirohito Tsubouchi; Akihiko Okayama; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2013-12-10       Impact factor: 4.174

Review 8.  Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors:  Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

9.  In vitro screening for the tumoricidal properties of international medicinal herbs.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Phytother Res       Date:  2009-03       Impact factor: 5.878

10.  Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.

Authors:  Susan J Zunino; David H Storms; John W Newman; Theresa L Pedersen; Carl L Keen; Jonathan M Ducore
Journal:  Int J Oncol       Date:  2012-10-04       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.